Reduced expression of p53 and cyclin A in intraductal mucin-hypersecretingneoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma
K. Mukawa et al., Reduced expression of p53 and cyclin A in intraductal mucin-hypersecretingneoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma, AM J GASTRO, 94(8), 1999, pp. 2263-2267
OBJECTIVE: Intraductal mucin-hypersecreting neoplasm (IMHN) of the pancreas
, a slow-growing malignancy with a favorable prognosis, is distinctly categ
orized from the high-grade malignancy of the more common ductal adenocarcin
oma. The aim of the present study was to clarify the molecular differences
underlying the biological differences between IMHN and ductal adenocarcinom
a of the pancreas.
METHODS: The expression of p53 and cyclin A in IMHN was compared with that
in ductal adenocarcinoma of the pancreas immunohistochemically.
RESULTS: In IMHN, the incidence of p53 and cyclin A ascertained by positive
nuclear staining was significantly lower than that in ductal adenocarcinom
a. Furthermore, in ductal adenocarcinoma, p53 and cyclin A are topographica
lly coexpressed.
CONCLUSIONS: These results suggest that the overexpression of p53 and cycli
n A plays a role in the tumorigenesis of pancreatic ductal adenocarcinoma,
and sparse expression of both antigens in IMHN may partly contribute to its
low-grade malignant characteristics. (Am J Gastroenterol 1999; 94.2263-226
7. (C) 1999 by Am. Coll, of Gastroenterology).